Times of India

US court orders Guardant Health to pay $245 million for cancer patent infringement

US court orders Guardant Health to pay $245 million for cancer patent infringementWorldPing

A federal judge ordered Guardant Health to pay over $245 million to TwinStrand Biosciences and the University of Washington. This judgment follows a jury verdict for infringing patented DNA sequencing technology.

This is a short WorldPing brief. The full report was published by Times of India.

Read the full report at Times of India

Related news